Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07265999

Severity Factors of Dermatomyositis in the Caribbean Population - DM-ANTILLES

Status
Recruiting
Phase
Study type
Observational
Enrollment
10 (estimated)
Sponsor
Centre Hospitalier Universitaire de la Guadeloupe · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

Dermatomyositis is a rare chronic autoimmune and inflammatory disease that affects the skin and striated muscles. Its prognosis is linked to visceral involvement (lungs, heart, and oropharyngeal region) and to the possible presence of associated cancer. The implementation of the research will allow identification of incident cases of dermatomyositis in Guadeloupe and the characterization of the disease in the overseas population, in the absence of data in the literature.

Detailed description

In the French West Indies, this condition is associated with high short- and medium-term morbidity and mortality. Diagnostic delays and patient care pathways may help explain this. However, a particularly severe phenotype of the disease in Antillean patients may also play a role, as observed in other autoimmune and inflammatory diseases we have described in overseas populations (e.g., systemic sclerosis, sarcoidosis). Identifying factors associated with the severity of dermatomyositis at the time of diagnosis would allow for the early implementation of a tailored management strategy to improve the disease prognosis in the target population.

Conditions

Timeline

Start date
2021-07-16
Primary completion
2029-07-16
Completion
2029-07-16
First posted
2025-12-05
Last updated
2025-12-05

Locations

1 site across 1 country: Guadeloupe

Source: ClinicalTrials.gov record NCT07265999. Inclusion in this directory is not an endorsement.